Replies to post #7760 on Repros Therapeutics, Inc. (RPRX)

[DewDiligence]

…the liver toxicity issues will be resolved!!!

That’s doubtful. A dose low enough to make the toxicity acceptable to the FDA will probably be too low to show meaningful efficacy.

Proellex has less than a 1% chance of making it to market, IMO. If a real drug/biotech company owned this drug, the program would almost certainly have been shelved by now.

[Romy]

I'm currently ride on 10,000 free shares after liquitdating with 17k profit yesterday. My gamble here to recover my losses at BLVI paid off. Good luck my friend.Love RPRX.